Ignite Creation Date:
2025-12-24 @ 5:51 PM
Ignite Modification Date:
2026-04-17 @ 12:17 AM
Study NCT ID:
NCT00829868
Status:
COMPLETED
Last Update Posted:
2024-08-21
First Post:
2009-01-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zaleplon 10 mg Capsules Under Non-Fasting Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
B046502
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None